SOBR Safe, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 5, 2020, details the closing of a material transaction between SOBR Safe, Inc. (formerly TransBiotec, Inc.) and IDTEC, LLC. The filing covers the consummation of an Asset Purchase Agreement (APA) originally dated May 6, 2019, and amended on March 9, 2020. Concurrently, the company effected a name change, a reverse stock split, and significant changes to its executive leadership.
Key Financial Metrics and Capital Structure
- Equity Issuance: Issued 12,000,000 shares of common stock (post-split) to IDTEC, LLC in exchange for robotics assets, personnel, experience, and funding access.
- Debt Instrument: Converted approximately $1,500,000 in prior loans and transaction-related expenditures by IDTEC into a convertible promissory note. The note carries a 10% simple interest rate, is due on demand, and is convertible at $0.50 per share.
- Security Interest: The promissory note is secured by a first-priority lien on the company's patents, trademarks, and other intellectual property.
- Warrant Issuance: Issued a warrant to IDTEC to purchase up to 320,000 shares at $0.50 per share, triggered by the existence of non-permitted liabilities exceeding the APA threshold.
- Liabilities: At closing, the company held approximately $158,000 in non-permitted liabilities, exceeding the APA limit of $125,000.
- Stock Split: Executed a 1-for-33.26 reverse stock split, reducing outstanding shares from approximately 266 million to 8 million prior to the transaction closing.
Material Changes Versus Prior Period
- Corporate Identity: Changed name from "TransBiotec, Inc." to "SOBR Safe, Inc." and received the new ticker symbol "SOBR" (effective July 3, 2020).
- Capitalization: Reduced authorized common stock from 800,000,000 to 100,000,000 shares.
- Management Changes:
- Charles Bennington resigned as President but remains Secretary and Board Member.
- Kevin Moore (CEO) assumed the role of Principal Executive Officer.
- Nick Noceti was terminated as Chief Financial Officer.
- David Gandini was appointed Interim Chief Financial Officer while retaining his role as Chief Revenue Officer.
- Asset Acquisition: Acquired robotics assets and development support from IDTEC, LLC.
Outlook, Risks, and Contingencies
- Contingent Liability: The company faces a contingent obligation where IDTEC may be forced to exercise the warrant to cover non-permitted liabilities if the company is forced to pay them.
- Dilution Risk: The $1,500,000 convertible note and the warrant introduce potential dilution at a fixed price of $0.50 per share, subject to anti-dilution protections.
- Liquidity and Debt: The convertible note is due on demand, creating a potential immediate liquidity requirement if IDTEC calls the debt.
- Trading Status: Shares are expected to trade on the "OTC Pink Current Information" tier starting June 8, 2020.
Investor Verification Checklist
- Verify the exact terms of the $1,500,000 convertible promissory note and the scope of the first-priority lien on intellectual property (Exhibit 10.3).
- Confirm the specific list of non-permitted liabilities totaling $158,000 that triggered the warrant issuance (Exhibit A of Warrant).
- Review the full Asset Purchase Agreement to understand the specific robotics assets acquired and the extent of IDTEC's ongoing obligations (Exhibit 10.1).
- Monitor the company's ability to meet the "on demand" repayment terms of the convertible note.
- Check the status of the new ticker symbol "SOBR" and trading volume on the OTC Pink tier post-June 8, 2020.